282 related articles for article (PubMed ID: 34198357)
21. Prescribing pattern of psychotropic drugs in nursing home residents with dementia.
Wetzels RB; Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
Int Psychogeriatr; 2011 Oct; 23(8):1249-59. PubMed ID: 21682938
[TBL] [Abstract][Full Text] [Related]
22. Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: variation in polypharmacy and antipsychotic use.
Pont LG; Raban MZ; Jorgensen ML; Georgiou A; Westbrook JI
Int J Qual Health Care; 2018 Dec; 30(10):810-816. PubMed ID: 29889231
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic medications and the transition into care: a national data linkage study.
Maguire A; Hughes C; Cardwell C; O'Reilly D
J Am Geriatr Soc; 2013 Feb; 61(2):215-21. PubMed ID: 23320828
[TBL] [Abstract][Full Text] [Related]
24. The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.
Shin HY; Gadzhanova S; Roughead EE; Ward MB; Pont LG
Int Psychogeriatr; 2016 Jun; 28(6):977-82. PubMed ID: 26775538
[TBL] [Abstract][Full Text] [Related]
25. Use of antipsychotics among older residents in VA nursing homes.
Gellad WF; Aspinall SL; Handler SM; Stone RA; Castle N; Semla TP; Good CB; Fine MJ; Dysken M; Hanlon JT
Med Care; 2012 Nov; 50(11):954-60. PubMed ID: 23047785
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
27. Trends in GP prescribing of psychotropic medications among young patients aged 16-24 years: a case study analysis.
Brijnath B; Xia T; Turner L; Mazza D
BMC Psychiatry; 2017 Jun; 17(1):214. PubMed ID: 28587610
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period.
Szczepura A; Wild D; Khan AJ; Owen DW; Palmer T; Muhammad T; Clark MD; Bowman C
BMJ Open; 2016 Sep; 6(9):e009882. PubMed ID: 27650756
[TBL] [Abstract][Full Text] [Related]
29. Is psychotropic medication use related to organisational and treatment culture in residential care.
Peri K; Kerse N; Moyes S; Scahill S; Chen C; Hong JB; Hughes CM
J Health Organ Manag; 2015; 29(7):1065-79. PubMed ID: 26556168
[TBL] [Abstract][Full Text] [Related]
30. Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study.
Svensson SA; Hedenrud TM; Wallerstedt SM
BMC Fam Pract; 2019 Jan; 20(1):4. PubMed ID: 30611211
[TBL] [Abstract][Full Text] [Related]
31. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
Mamun K; Goh-Tan CY; Ng LL
Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
[TBL] [Abstract][Full Text] [Related]
32. The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes.
Grill P; Marwick C; De Souza N; Burton JK; Hughes C; Guthrie B
Age Ageing; 2021 Jan; 50(1):183-189. PubMed ID: 32706851
[TBL] [Abstract][Full Text] [Related]
33. Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia.
Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA
BMC Health Serv Res; 2018 Dec; 18(1):1009. PubMed ID: 30594192
[TBL] [Abstract][Full Text] [Related]
34. Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.
Kristensen RU; Nørgaard A; Jensen-Dahm C; Gasse C; Wimberley T; Waldemar G
J Alzheimers Dis; 2018; 63(1):383-394. PubMed ID: 29578483
[TBL] [Abstract][Full Text] [Related]
35. Psychotropic, Anticonvulsant, and Opioid Use in Assisted Living Residents Before and During the COVID-19 Pandemic.
Maxwell CJ; Dampf H; Alkabbani W; Cotton CA; Gamble JM; Hogan DB; Gruneir A; McArthur E; Youngson E; Hsu Z; Hoben M
J Am Med Dir Assoc; 2024 Jan; 25(1):121-129. PubMed ID: 37863111
[TBL] [Abstract][Full Text] [Related]
36. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.
Jester DJ; Molinari V; Zgibor JC; Volicer L
Int Psychogeriatr; 2021 Oct; 33(10):1083-1098. PubMed ID: 33407955
[TBL] [Abstract][Full Text] [Related]
38. Potentially inappropriate prescribing in people with dementia: An Australian population-based study.
Eshetie TC; Nguyen TA; Gillam MH; Kalisch Ellett LM
Int J Geriatr Psychiatry; 2019 Oct; 34(10):1498-1505. PubMed ID: 31173395
[TBL] [Abstract][Full Text] [Related]
39. Variation in benzodiazepine and antipsychotic use in people aged 65 years and over in New Zealand.
Jackson G; Gerard C; Minko N; Parsotam N
N Z Med J; 2014 Jun; 127(1396):67-78. PubMed ID: 24997465
[TBL] [Abstract][Full Text] [Related]
40. The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial.
Gedde MH; Husebo BS; Mannseth J; Naik M; Selbaek G; Vislapuu M; Berge LI
BMC Med; 2022 May; 20(1):186. PubMed ID: 35614509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
